Literature DB >> 17361211

Burden of carotid atherosclerosis in patients with stroke: relationships with circulating endothelial progenitor cells and hypertension.

K-K Lau1, Y-H Chan, K-H Yiu, S-W Li, S Tam, C-P Lau, Y-L Kwong, H-F Tse.   

Abstract

Recent studies suggest that reductions in circulating endothelial progenitor cells (EPCs) may contribute to the development of atherosclerosis. However, whether reduced circulating EPCs contribute to cerebrovascular disease remains undefined. We tested the hypothesis that reduced circulating EPCs was associated with an increased burden of carotid atherosclerosis. The level of circulating CD34+/KDR+ EPCs and the extent of carotid atherosclerosis were determined in 30 patients with a history of atherothrombotic ischaemic stroke and 30 age- and sex-matched controls (mean age: 63+/-2 years; 63% men). Stroke patients, compared with controls, had significantly higher carotid mean maximum intima-media thickness (mmIMT) (1.08+/-0.05 versus 0.90+/-0.02 mm, P=0.002), prevalence of carotid plaque (60.0 versus 23.3%, P=0.004) and a lower number of circulating CD34+/KDR+ EPCs (235.7+/-45.5 versus 400.4+/-56.8 cells/mul, P=0.027). The circulating CD34+/KDR+ EPC count correlated negatively with carotid mmIMT (r=-0.50, P<0.001), and was an independent risk factor for increased carotid mmIMT>1 mm (odds ratio (OR): 7.71; 95% confidence interval (CI): 1.62-36.74, P=0.010) and the presence of carotid plaque (OR: 7.04; 95% CI: 1.95-25.43, P=0.003). Furthermore, stroke patients with low (<25th percentile of controls) as compared to those with normal CD34+/KDR+ EPC count had a significantly greater carotid mmIMT (1.21+/-0.07 versus 0.93+/-0.05 mm, P=0.005) and a significantly higher prevalence of carotid plaque (87.5% versus 28.6%; P=0.001). Our observations suggested that reduced circulating EPC may contribute to the progression of carotid atherosclerosis. Circulating EPC count may provide a novel marker for the burden of carotid atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17361211     DOI: 10.1038/sj.jhh.1002178

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  20 in total

1.  Effects of ACE inhibition on circulating endothelial progenitor cells, vascular damage, and oxidative stress in hypertensive patients.

Authors:  Francesco Cacciatore; Giuseppe Bruzzese; Dino Franco Vitale; Antonio Liguori; Filomena de Nigris; Carmela Fiorito; Teresa Infante; Francesco Donatelli; Pellegrino Biagio Minucci; Louis Joseph Ignarro; Claudio Napoli
Journal:  Eur J Clin Pharmacol       Date:  2011-03-29       Impact factor: 2.953

Review 2.  Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use.

Authors:  Gian Paolo Fadini; Douglas Losordo; Stefanie Dimmeler
Journal:  Circ Res       Date:  2012-02-17       Impact factor: 17.367

3.  Circulating CD133+ CD34+ progenitor cells and plasma stromal-derived factor-1alpha: predictive role in ischemic stroke patients.

Authors:  Yusen Chen; Bing Lu; Jinju Wang; Shuzhen Chen; Zhijun Lin; Xiaotang Ma; Yajing Liu; Bin Zhao; Yanfang Chen
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-11-22       Impact factor: 2.136

4.  Association of colony-forming units with coronary artery and abdominal aortic calcification.

Authors:  Susan Cheng; Kenneth S Cohen; Stanley Y Shaw; Martin G Larson; Shih-Jen Hwang; Elizabeth L McCabe; Roderick P Martin; Rachael J Klein; Basma Hashmi; Udo Hoffmann; Caroline S Fox; Ramachandran S Vasan; Christopher J O'Donnell; Thomas J Wang
Journal:  Circulation       Date:  2010-09-07       Impact factor: 29.690

5.  Circulating endothelial progenitor cells are reduced in SLE in the absence of coronary artery calcification.

Authors:  Joshua F Baker; Lifeng Zhang; Sotonye Imadojemu; Alexis Sharpe; Sarita Patil; Jonni S Moore; Emile R Mohler; Joan Von Feldt
Journal:  Rheumatol Int       Date:  2011-01-19       Impact factor: 2.631

Review 6.  Global trends, potential mechanisms and early detection of organ damage in SLE.

Authors:  Anselm Mak; David A Isenberg; Chak-Sing Lau
Journal:  Nat Rev Rheumatol       Date:  2012-12-11       Impact factor: 20.543

7.  Circulating CD133+CD34+ progenitor cells inversely correlate with soluble ICAM-1 in early ischemic stroke patients.

Authors:  Tanya Bogoslovsky; Maria Spatz; Aneeka Chaudhry; Dragan Maric; Marie Luby; Joseph Frank; Steven Warach
Journal:  J Transl Med       Date:  2011-08-26       Impact factor: 5.531

Review 8.  Endothelial progenitor cells in ischemic stroke: an exploration from hypothesis to therapy.

Authors:  Ya-Feng Li; Li-Na Ren; Geng Guo; Lee Anne Cannella; Valeria Chernaya; Sonia Samuel; Su-Xuan Liu; Hong Wang; Xiao-Feng Yang
Journal:  J Hematol Oncol       Date:  2015-04-11       Impact factor: 17.388

9.  Circulating endothelial progenitor cells in cerebrovascular disease.

Authors:  Keun-Hwa Jung; Jae-Kyu Roh
Journal:  J Clin Neurol       Date:  2008-12-31       Impact factor: 3.077

10.  Myocardial dysfunction in patients with type 2 diabetes mellitus: role of endothelial progenitor cells and oxidative stress.

Authors:  Chun Ting Zhao; Mei Wang; Chung Wah Siu; Ying Long Hou; Tian Wang; Hung Fat Tse; Kai Hang Yiu
Journal:  Cardiovasc Diabetol       Date:  2012-12-05       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.